Article

Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis.

Department of Internal Medicine II, University of Cologne, Cologne, Germany.
Experimental and Clinical Endocrinology &amp Diabetes (impact factor: 1.69). 06/2005; 113(5):302-7. DOI:10.1055/s-2005-837551 pp.302-7
Source: PubMed

ABSTRACT The autoimmune polyglandular syndrome (APS) is characterized by a variable coexistence of several autoimmune diseases, affecting predominantly endocrine glands. In general two types of APS are distinguished. Type 1 APS is an autosomal recessive disorder often leading to insufficiency of the adrenal cortex, the parathyroid glands, and/or the gonads. This type of APS often affects the skin in form of chronic mucocutaneous candidiasis and ectodermal dystrophies (vitiligo, alopecia, keratopathy, dystrophy of dental enamel and nails). The second form of APS is a polygenic disease which usually involves the adrenal gland, the thyroid and the pancreatic beta-cells. In rare cases APS type 2 is associated with myasthenia gravis, autoimmune thrombocytopenic purpura, Sjogren's syndrome or rheumatoid arthritis. Here we describe a case of APS with the unusual combination of type 1 diabetes, secondary adrenocortical insufficiency, growth hormone deficiency, and primary hypothyroidism associated with lethal idiopathic giant cell myocarditis. The combination of APS and idiopathic giant cell myocarditis which is a rare, frequently fatal autoimmune disorder of myocardium affecting most commonly young individuals has not been reported so far.

0 0
 · 
0 Bookmarks
 · 
24 Views

Keywords

adrenal cortex
 
autoimmune diseases
 
autoimmune polyglandular syndrome
 
autoimmune thrombocytopenic purpura
 
autosomal recessive disorder
 
chronic mucocutaneous candidiasis
 
dental enamel
 
ectodermal dystrophies
 
fatal autoimmune disorder
 
growth hormone deficiency
 
idiopathic giant cell myocarditis
 
lethal idiopathic giant cell myocarditis
 
myasthenia gravis
 
pancreatic beta-cells
 
primary hypothyroidism
 
rare cases APS type 2
 
secondary adrenocortical insufficiency
 
type 1 diabetes
 
variable coexistence
 
young individuals